Acetylcysteine

CHEMBL600 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
163.2 g/mol
LogP
0.4
Phase
4

A medication that replenishes glutathione, a key antioxidant in the body, and is used as the primary antidote for acetaminophen overdose to prevent liver failure. It also thins and loosens thick mucus in the airways, making it useful in conditions such as cystic fibrosis, chronic bronchitis, and to clear mucus before respiratory procedures. When given intravenously for overdose, it is most effective when started within eight hours of ingestion.

分子量

163.2000 g/mol

LogP

0.40

TPSA

67.40 Ų

リピンスキーの五則

適合

治療領域

作用機序

Counteracts the effects of a specific toxin or drug overdose through competitive antagonism, enhanced elimination, or direct chemical neutralization.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

機序

Counteracts the effects of a specific toxin or drug overdose through competitive antagonism, enhanced elimination, or direct chemical neutralization.

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(=O)N[C@@H](CS)C(=O)O

InChI

InChI=1S/C5H9NO3S/c1-3(7)6-4(2-10)5(8)9/h4,10H,2H2,1H3,(H,6,7)(H,8,9)/t4-/m0/s1

Molecular Formula

C5H9NO3S

HBD / HBA

3 / 4

回転可能結合数

3

重原子数

10

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A medication that replenishes glutathione, a key antioxidant in the body, and is used as the primary antidote for acetaminophen overdose to prevent liver failure. It also thins and loosens thick mucus in the airways, making it useful in conditions such as cystic fibrosis, chronic bronchitis, and to clear mucus before respiratory procedures. When given intravenously for overdose, it is most effective when started within eight hours of ingestion.

Counteracts the effects of a specific toxin or drug overdose through competitive antagonism, enhanced elimination, or direct chemical neutralization.

Yes, Acetylcysteine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL600. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 12035. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.